about
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.Risk acceptance in multiple sclerosis patients on natalizumab treatment.Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.Defining high, medium and low impact prognostic factors for developing multiple sclerosis.Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision
P50
Q31042055-25FCCCE0-C4C5-4526-A260-73D9F6B9CDC4Q35067882-7470992E-CFD7-4901-A977-CEE4A543FD58Q39156637-255A67FB-1E59-41BF-B5B1-49FC5845DCDFQ40413987-632634C5-ADBF-4576-8187-675EAB1D3394Q41029094-8F5E761D-F915-4103-8FDB-87EDEDF8F74CQ48210503-216E8926-CFBA-45B0-A5C2-7D2FC98528AEQ48328849-B8E89D9A-7178-44D4-A47D-56006EC82631Q51026344-278FB1D5-36B3-4DC3-9CAD-677346720A06Q57601863-9426B702-C71D-45DE-BE08-67E6BF1C38F2
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0626-5555
@en
name
María Jesús Arévalo
@ast
María Jesús Arévalo
@en
María Jesús Arévalo
@es
María Jesús Arévalo
@nl
type
label
María Jesús Arévalo
@ast
María Jesús Arévalo
@en
María Jesús Arévalo
@es
María Jesús Arévalo
@nl
prefLabel
María Jesús Arévalo
@ast
María Jesús Arévalo
@en
María Jesús Arévalo
@es
María Jesús Arévalo
@nl
P106
P1153
36742881600
P21
P31
P496
0000-0003-0626-5555